105 related articles for article (PubMed ID: 21625196)
1. The role of phosphatidylinositol 3-kinase signaling pathways in pancreatic cancer.
Sun C; Rosendahl AH; Andersson R; Wu D; Wang X
Pancreatology; 2011; 11(2):252-60. PubMed ID: 21625196
[TBL] [Abstract][Full Text] [Related]
2. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy.
Holcomb B; Yip-Schneider M; Schmidt CM
Pancreas; 2008 Apr; 36(3):225-35. PubMed ID: 18362834
[TBL] [Abstract][Full Text] [Related]
3. The integrin-extracellular matrix axis in pancreatic cancer.
Grzesiak JJ; Ho JC; Moossa AR; Bouvet M
Pancreas; 2007 Nov; 35(4):293-301. PubMed ID: 18090233
[TBL] [Abstract][Full Text] [Related]
4. Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway.
Saleem M; Kaur S; Kweon MH; Adhami VM; Afaq F; Mukhtar H
Carcinogenesis; 2005 Nov; 26(11):1956-64. PubMed ID: 15958516
[TBL] [Abstract][Full Text] [Related]
5. PI3K inhibitors as novel cancer therapies: implications for cardiovascular medicine.
McLean BA; Zhabyeyev P; Pituskin E; Paterson I; Haykowsky MJ; Oudit GY
J Card Fail; 2013 Apr; 19(4):268-82. PubMed ID: 23582093
[TBL] [Abstract][Full Text] [Related]
6. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
[TBL] [Abstract][Full Text] [Related]
7. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
[TBL] [Abstract][Full Text] [Related]
8. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
[TBL] [Abstract][Full Text] [Related]
9. Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer.
Stoll V; Calleja V; Vassaux G; Downward J; Lemoine NR
Gut; 2005 Jan; 54(1):109-16. PubMed ID: 15591514
[TBL] [Abstract][Full Text] [Related]
10. Targeting the phosphatidylinositol 3-kinase pathway in multiple myeloma.
Younes H; Leleu X; Hatjiharissi E; Moreau AS; Hideshima T; Richardson P; Anderson KC; Ghobrial IM
Clin Cancer Res; 2007 Jul; 13(13):3771-5. PubMed ID: 17606706
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell metabolism: cancer's Achilles' heel.
Kroemer G; Pouyssegur J
Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
[TBL] [Abstract][Full Text] [Related]
12. Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer.
El Maalouf G; Le Tourneau C; Batty GN; Faivre S; Raymond E
Cancer Treat Rev; 2009 Apr; 35(2):167-74. PubMed ID: 19027240
[TBL] [Abstract][Full Text] [Related]
13. Rationale for inhibition of the hedgehog pathway paracrine loop in pancreatic adenocarcinoma.
Dimou A; Syrigos K; Saif MW
JOP; 2011 Jan; 12(1):1-5. PubMed ID: 21206093
[TBL] [Abstract][Full Text] [Related]
14. Molecular aspects of carcinogenesis in pancreatic cancer.
Koliopanos A; Avgerinos C; Paraskeva C; Touloumis Z; Kelgiorgi D; Dervenis C
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):345-56. PubMed ID: 18693168
[TBL] [Abstract][Full Text] [Related]
15. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-gene signaling pathways in pancreatic cancer.
Drakaki A; Iliopoulos D
Biomed J; 2013; 36(5):200-8. PubMed ID: 24225187
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell signaling in cancer progression.
Torsvik A; Bjerkvig R
Cancer Treat Rev; 2013 Apr; 39(2):180-8. PubMed ID: 22494966
[TBL] [Abstract][Full Text] [Related]
18. Cathepsins and pancreatic cancer: the 2012 update.
Sulpizio S; Franceschini N; Piattelli A; Di Sebastiano P; Innocenti P; Selvaggi F
Pancreatology; 2012; 12(5):395-401. PubMed ID: 23127526
[TBL] [Abstract][Full Text] [Related]
19. Recent advances and developments in treatment strategies against pancreatic cancer.
Fryer RA; Galustian C; Dalgleish AG
Curr Clin Pharmacol; 2009 May; 4(2):102-12. PubMed ID: 19442075
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 4-kinases, phosphatidylinositol 4-phosphate and cancer.
Waugh MG
Cancer Lett; 2012 Dec; 325(2):125-31. PubMed ID: 22750097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]